These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3106077)

  • 1. Effect of recombinant gamma interferon on chronic myelogenous leukemia bone marrow progenitors.
    McGlave P; Mamus S; Vilen B; Dewald G
    Exp Hematol; 1987 May; 15(4):331-5. PubMed ID: 3106077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and selection of benign stem cells in chronic myeloid leukemia.
    Lemoli RM
    Haematologica; 1993; 78(6):393-400. PubMed ID: 8175034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures.
    Chávez-González A; Ayala-Sánchez M; Sánchez-Valle E; Ruiz-Sánchez E; Arana-Trejo RM; Vela-Ojeda J; Mayani H
    Leuk Res; 2006 Mar; 30(3):286-95. PubMed ID: 16111748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: synergism with interferon-gamma.
    Herrmann F; Bambach T; Bonifer R; Lindemann A; Riedel D; Oster W; Mertelsmann R
    Int J Cell Cloning; 1988 Jul; 6(4):241-61. PubMed ID: 3138311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of recombinant human alpha-2b and gamma interferons on bone marrow megakaryocyte progenitors (CFU-Meg) from patients with chronic myelocytic leukemia].
    Tanabe Y; Dan K; Kuriya S; Nomura T
    Rinsho Ketsueki; 1989 Oct; 30(10):1800-5. PubMed ID: 2512397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent antileukemic activity of the novel agents norsegoline and dibezine.
    Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
    Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observations.
    O'Brien S; Kantarjian HM; Talpaz M; Cork A; Trujillo J; Beran M
    Hematol Pathol; 1987; 1(3):167-72. PubMed ID: 3509052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
    Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J
    Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.
    Aswald JM; Lipton JH; Messner HA
    Cytokines Cell Mol Ther; 2002 Dec; 7(2):75-82. PubMed ID: 12607798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
    Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.
    Mamus SW; Oken MM; Zanjani ED
    Exp Hematol; 1986 Dec; 14(11):1015-22. PubMed ID: 3780887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of chromosomal findings in Ph1-positive chronic myelocytic leukemia.
    Sakurai M; Hayata I; Sandberg AA
    Cancer Res; 1976 Feb; 36(2 Pt 1):313-8. PubMed ID: 1063061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon gamma is effective for BM purging in a patient with CML.
    Becker M; Fabrega S; Belloc F; Rice A; Barbu V; Reiffers J
    Bone Marrow Transplant; 1993 Aug; 12(2):155-8. PubMed ID: 8401363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
    Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.